Moderna Jumps as Analyst Sees Over $5 Billion Vaccine Sales

(Bloomberg) -- Moderna Inc. surged on Monday, spurred by a positive review from a Jefferies analyst who said the biotechnology company’s experimental vaccine for Covid-19 could generate sales of mo...